Review Fisch, P., Handgretinger, R. & Schaefer, H.E. (2000) Pure red cell aplasia. British Journal of Haematology, 111, 1010–1122. Frickhofen, N., Abkowitz, J.L., Safford, M., Berry, J.M., Antunez-de- Mayolo, J., Astrow, A., Cohen, R., Halperin, I., King, L., Mintzer, D., Cohen, B. & Young, N.S. (1990) Persistent B19 parvovirus infection in patients infected with human immunodeﬁciency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Annals of Internal Medicine, 113, 926–933. Garcia Vela, J.A., Monteserin, M.C., On˜a, F., Barea, L.M., Lastra, A. & Pe´rez, V. (1993) Cyclosporine A used as a single drug in the treat- ment of pure red cell aplasia associated with thymoma. American Journal of Hematology, 42, 238–239. Gerli, R., Paganelli, R., Cossarizza, A., Muscat, C., Piccolo, G., Barbieri, D., Mariotti, S., Monti, D., Bistoni, O., Raiola, E., Venanzi, F.M., Bertotto, A. & Franceschi, C. (1999) Long-term immunologic effects of thymectomy in patients with myasthenia gravis. Journal of Allergy and Clinical Immunology, 103, 865–872. Ghazal, H. (2002) Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia. Blood, 99, 1092–1094. Go, R.S., Li, C.Y., Tefferi, A. & Phyliky, R.L. (2001) Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood, 98, 483–485. Go, R.S., Lust, J.A. & Phyliky, R.L. (2003) Aplastic anemia and pure red cell aplasia associated with large granular lymphocyte leukemia. Seminars in Hematology, 40, 196–200. Gonzales-Chambers, R., Przepiorka, D., Winkelstein, A., Agarwal, A., Starz, T.W., Kline, W.E. & Hawk, H. (1992) Lymphocyte subsets associated with T cell receptor P-chain gene rearrangement in patients with rheumatoid arthritis and neutropenia. Arthritis & Rheumatism, 35, 516–520. Gupta, N., Kavuru, S., Patel, D., Janson, D., Driscoll, N., Ahmed, S. & Rai, K.R. (2002) Rituximab-based chemotherapy for steroid- refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia. Leukemia, 16, 2092–2095. Hale, G. (2001) The CD52 antigen and development of the Campath antibodies. Cytotherapy, 3, 137–143. Hamidou, M.A., Sadr, F.B., Lamy, T., Rafﬁ, F., Grolleau, J.Y. & Barrier, J.H. (2000) Low-dose methotrexate for the treatment of patients with large granular lymphocyte leukemia associated with rheuma- toid arthritis. American Journal of Medicine, 108, 730–732. Hegde, U.P., Wilson, W.H., White, T. & Cheson, B.D. (2002) Ritux- imab treatment of refractory ﬂudarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia. Blood, 100, 2260–2262. Herbert, K.E., Prince, H.M. & Westerman, D.A. (2003) Pure red-cell aplasia due to parvovirus B19 infection in a patient treated with alemtuzumab. Blood, 101, 1654. Hirokawa, M., Sawada, K., Fujishima, N., Nakao, S., Urabe, A., Dan, K., Fujisawa, S., Yonemura, Y., Kawano, F., Omine, M., Ozawa, K. & for the PRCA Collaborative Study Group. (2008) Long-Term response and outcome following immunosuppressive therapy in thymoma- associated pure red cell aplasia: a nationwide cohort study in Japan for the PRCA collaborative study group. Haematologica, 93, 27–33. Hoffacker, V., Schultz, A., Tiesinga, J.J., Gold, R., Schalke, B., Nix, W., Kiefer, R., Muller-Hermelink, H.K. & Marx, A. (2000) Thymomas alter the T-cell subset composition in the blood: a potential mech- anism for thymoma-associated autoimmune disease. Blood, 96, 3872–3879. Hoffman, G.S., Kerr, G.S., Leavitt, R.Y., Hallahan, C.W., Lebovics, R.S., Travis, W.D., Rottem, M. & Fauci, A.S. (1992) Wegener granulo- matosis: an analysis of 158 patients. Annals of Internal Medicine, 116, 488–498. Isobe, Y., Sugimoto, K., Shiraki, Y., Nishitani, M., Koike, K. & Oshimi, K. (2004) Successful high-titer immunoglobulin therapy for persis- tent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy. American Journal of Hematol- ogy, 77, 370–373. Kaznelson, P. (1922) Zur Entstehung der Blutpla¨ttchen. Verhandlungen der Deutschen Gesellschaft Fur Innere Medizin, 34, 557–558. Keating, M.J., Flinn, I., Jain, V., Binet, J.L., Hillmen, P., Byrd, J., Albitar, M., Brettman, L., Santabarbara, P., Wacker, B. & Rai, K.R. (2002) Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed ﬂudarabine: results of a large international study. Blood, 99, 3554–3561. Krantz, S.B. & Kao, V. (1967) Studies on red cell aplasia. I. Demon- stration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei. Proceedings of the National Academy of Sciences of the United States of America, 58, 493–500. Lacy, M.Q., Kurtin, P.J. & Tefferi, A. (1996) Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood, 87, 3000–3006. Lamy, T. & Loughran, T.P. (1998) Large granular lymphocyte leuke- mia. Cancer Control, 5, 25–33. Lamy, T. & Loughran, Jr, T.P. (2003) Clinical features of large granular lymphocyte leukemia. Seminars in Hematology, 40, 185–195. Loughran, Jr, T.P. (1993) Clonal diseases of large granular lympho- cytes. Blood, 82, 1–14. Loughran, Jr, T.P. & Starkebaum, G. (1987) Large granular lymphocyte leukemia: report of 38 cases and review of the literature. Medicine (Baltimore), 66, 397–405. Loughran, Jr, T.P., Draves, K.E., Starkebaum, G., Kidd, P. & Clark, C.A. (1987) Induction of NK activity in large granular lymphocyte leukemia: activation with anti-CD3 monoclonal antibody and interleukin 2. Blood, 69, 72–78. Loughran, Jr, T.P., Kidd, P.G. & Starkebaum, G. (1994) Treatment of large granular lymphocyte leukemia with oral low-dose methotrex- ate. Blood, 84, 2164–2170. Mamiya, S., Itoh, T. & Miura, A.B. (1997) Acquired pure red cell aplasia in Japan. European Journal of Haematology, 59, 199–205. Marmont, A.M. (1991) Therapy of pure red cell aplasia. Seninars in Hematology, 28, 285–297. Marmont, A., Peschle, C., Sanguineti, M. & Condorelli, M. (1975) Pure red cell aplasia (PRCA): response of three patients of cyclophos- phamide and/or antilymphocyte globulin (ALG) and demonstration of two types of serum IgG inhibitors to erythropoiesis. Blood, 45, 247–261. Means, Jr, R.T., Dessypris, E.N. & Krantz, S.B. (1991) Treatment of refractory pure red cell aplasia with cyclosporine A: disappearance of IgG inhibitor associated with clinical response. British Journal of Haematology, 78, 114–119. Mylonakis, E., Dickinson, B.P., Mileno, M.D., Flanigan, T., Schiffman, F.J., Mega, A. & Rich, J.D. (1999) Persistent parvovirus B19 related anemia of seven years’ duration in an HIV-infected patient: com- plete remission associated with highly active antiretroviral therapy. American Journal of Hematology, 60, 164–166. Narra, K., Borghaei, H., Al-Saleem, T., Ho¨glund, M. & Smith, M.R. (2006) Pure red cell aplasia in B-cell lymphoproliferative disorder 512 ª 2008 The Authors Journal Compilation ª 2008 Blackwell Publishing Ltd, British Journal of Haematology, 142, 505–514